RT @FrontOncology: 📣 Catch up on the latest research on T-cell engaging bispecific antibodies targeting myeloma stem cells and myeloid-deri…
📣 Catch up on the latest research on T-cell engaging bispecific antibodies targeting myeloma stem cells and myeloid-derived suppressor cells in the treatment of #Myeloma! Full #OpenAccess article ➡ https://t.co/FMrYjEetSk #MyelomaAwarenessMonth #Multiple
New article: Dual Targeting of Multiple Myeloma Stem Cells and Myeloid-Derived Suppressor Cells for Treatment of Chemotherapy-Resistant Multiple Myeloma https://t.co/8cAI89rMpu #MMSM #MultipleMyeloma #hematology https://t.co/z9h819lFOr
New research: Dual Targeting of Multiple Myeloma Stem Cells and Myeloid-Derived Suppressor Cells for Treatment of Chemotherapy-Resistant Multiple Myeloma: Here we review the insights and lessons learned from early clinical trials of T-cell… https://t.co/ho